CagriSema: Research in the Synergistic Agonism of GLP-1 and Amylin Pathways
No Comments on CagriSema: Research in the Synergistic Agonism of GLP-1 and Amylin Pathways
May 11, 2026 CagriSema is a fixed-dose combination research compound consisting of two potent long-acting peptides: Cagrilintide and Semaglutide. Research indicates that CagriSema represents a breakthrough in multi-modal metabolic therapy, aiming to…